Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase - PubMed (original) (raw)
Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase
S Reddy et al. FEBS Lett. 1994.
Free article
Abstract
Recently, we reported that curcumin (diferuloylmethane) inhibits the growth of several different kinds of tumor cells. In order to investigate the mechanism of this inhibition, we examined the effects of curcumin on different protein kinases: highly purified protein kinase A (PkA), protein kinase C (PkC), protamine kinase (cPK), phosphorylase kinase (PhK), autophosphorylation-activated protein kinase (AK) and pp60c-src tyrosine kinase. While all kinases tested were inhibited by curcumin, only PhK was completely inhibited at relatively lower concentrations. At around 0.1 mM curcumin, PhK, pp60c-src, PkC, PkA, AK, and cPK were inhibited by 98%, 40%, 15%, 10%, 1%, and 0.5%, respectively. Lineweaver-Burk plot analysis indicated that curcumin is a non-competitive inhibitor of PhK with a Ki of 0.075 mM. Overall, our results indicate that curcumin is a potent and selective inhibitor of phosphorylase kinase, a key regulatory enzyme involved in the metabolism of glycogen. This has important implications for the anti-proliferative effects of curcumin.
Similar articles
- In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract.
Nardini M, Scaccini C, Packer L, Virgili F. Nardini M, et al. Biochim Biophys Acta. 2000 Apr 6;1474(2):219-25. doi: 10.1016/s0304-4165(00)00009-x. Biochim Biophys Acta. 2000. PMID: 10742602 - Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.
Heng MC, Song MK, Harker J, Heng MK. Heng MC, et al. Br J Dermatol. 2000 Nov;143(5):937-49. doi: 10.1046/j.1365-2133.2000.03767.x. Br J Dermatol. 2000. PMID: 11069500 Clinical Trial. - Signaling pathways targeted by curcumin in acute and chronic injury: burns and photo-damaged skin.
Heng MC. Heng MC. Int J Dermatol. 2013 May;52(5):531-43. doi: 10.1111/j.1365-4632.2012.05703.x. Epub 2012 Dec 11. Int J Dermatol. 2013. PMID: 23231506 Review. - An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
Begum J, Skamnaki VT, Moffatt C, Bischler N, Sarrou J, Skaltsounis AL, Leonidas DD, Oikonomakos NG, Hayes JM. Begum J, et al. J Mol Graph Model. 2015 Sep;61:231-42. doi: 10.1016/j.jmgm.2015.07.010. Epub 2015 Aug 3. J Mol Graph Model. 2015. PMID: 26364215 - Substrate and inhibitor recognition of protein kinases: what is known about the catalytic subunit of phosphorylase kinase?
Graves D, Bartleson C, Biorn A, Pete M. Graves D, et al. Pharmacol Ther. 1999 May-Jun;82(2-3):143-55. doi: 10.1016/s0163-7258(98)00049-7. Pharmacol Ther. 1999. PMID: 10454193 Review.
Cited by
- Effects of curcumin on the gene expression profile of L-02 cells.
Zhou M, Fan C, Tian N. Zhou M, et al. Biomed Rep. 2015 Jul;3(4):519-526. doi: 10.3892/br.2015.460. Epub 2015 May 4. Biomed Rep. 2015. PMID: 26171159 Free PMC article. - Multitargeting by curcumin as revealed by molecular interaction studies.
Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB. Gupta SC, et al. Nat Prod Rep. 2011 Nov;28(12):1937-55. doi: 10.1039/c1np00051a. Epub 2011 Oct 6. Nat Prod Rep. 2011. PMID: 21979811 Free PMC article. Review. - Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells.
Rogers NM, Stephenson MD, Kitching AR, Horowitz JD, Coates PT. Rogers NM, et al. Br J Pharmacol. 2012 May;166(1):194-209. doi: 10.1111/j.1476-5381.2011.01590.x. Br J Pharmacol. 2012. PMID: 21745189 Free PMC article. - Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats.
Reddy BV, Sundari JS, Balamurugan E, Menon VP. Reddy BV, et al. Mol Cell Biochem. 2009 Nov;331(1-2):127-33. doi: 10.1007/s11010-009-0150-1. Epub 2009 May 26. Mol Cell Biochem. 2009. PMID: 19468831 - NDS27 combines the effect of curcumin lysinate and hydroxypropyl-β-cyclodextrin to inhibit equine PKCδ and NADPH oxidase involved in the oxidative burst of neutrophils.
Derochette S, Mouithys-Mickalad A, Franck T, Collienne S, Ceusters J, Deby-Dupont G, Neven P, Serteyn D. Derochette S, et al. FEBS Open Bio. 2014 Nov 18;4:1021-9. doi: 10.1016/j.fob.2014.11.004. eCollection 2014. FEBS Open Bio. 2014. PMID: 25493216 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous